Idorsia.
company in Allschwil, Switzerland
- Reports this week
- 0
- Active events
- 0
- Connections
- 19
What's happening
Gone quiet
No new reports in 90+ days-
Idorsia, a Swiss biopharmaceutical company, was spun off following an acquisition by Johnson & Johnson from Actelion.Some support1 report
-
Nike forecasts a surprise drop in annual revenue, while Aker sells Cognite and Idorsia appoints a new CEO.Some support1 report
-
Idorsia appoints Roland Wandeler as CEO, who previously held senior roles at Morphosys and Amgen.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Around Idorsia this week
News at the entities that move Idorsia most-
Johnson & Johnson TransactionalCoca-Cola and Johnson & Johnson announced dividend raises, while SmartAsset continues to assist users with retirement planning.Moves Idorsia
-
Arlington Shared contextCNN reported on the arrest of Miguel Alonso in Arlington, Virginia.Moves Idorsia
-
Switzerland Shared contextA report analyzes the ongoing trend of private bank consolidation within Switzerland.Moves Idorsia
Connections
The 8 strongest of 19, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Roland Structural
Roland is appointed as CEO of Idorsia, tasked with leading the company's growth and operational direction.
-
Jean-Paul Clozel Structural
Jean-Paul Clozel served and is forecast to serve as the CEO of Idorsia.
-
Johnson & Johnson Transactional
Idorsia was acquired by Johnson & Johnson, leading to its subsequent spin-off.
-
Actelion Structural
Idorsia was established as a spin-off entity from Actelion.
-
Allschwil Shared context
Idorsia is headquartered in Allschwil.
-
Arlington Shared context
Idorsia presented findings at a conference held in Arlington, VA.
-
Switzerland Shared context
Idorsia is a company headquartered and operating within the geographical and legal context of Switzerland.
-
Aker Mentioned together
Co-mention evidence suggests potential co-existence, though the available snapshot only details Idorsia's internal leadership appointment.
History
Events by the month they beganJuly 2026
3 events- Idorsia, a Swiss biopharmaceutical company, was spun off following an acquisition by Johnson & Johnson from Actelion.
- Nike forecasts a surprise drop in annual revenue, while Aker sells Cognite and Idorsia appoints a new CEO.
- Idorsia appoints Roland Wandeler as CEO, who previously held senior roles at Morphosys and Amgen.